Douglas Conrad, MD, Pulmonology, La Jolla, CA, UC San Diego Medical Center – Hillcrest

DouglasJohnConradMD

Pulmonology La Jolla, CA

Pleural Disease

Professor of Medicine, UCSD

Dr. Conrad is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Conrad's full profile

Already have an account?

Education & Training

  • UCSF
    UCSFFELLOWSHIP
  • University of Minnesota Affiliated HospitalsRESIDENCY
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineMEDICAL_SCHOOL
  • Case Western Reserve UniversityOTHER_TRAINING

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2021
  • MN State Medical License
    MN State Medical License 1986 - 1988
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology  
    Theilmann RJ, Darquenne C, Elliott AR, Bailey BA, Conrad D, PLoS One, 1/23/2016
  • A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT...  
    Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE, Elborn JS, Cyst Fibros, 1/1/2016
  • A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in sta...  
    Stuart Elborn J, Geller DE, Conrad D, Aaron SD, Smyth AR, Fischer R, Kerem E, Bell SC, Loutit JS, Dudley MN, Morgan EE, VanDevanter DR, Flume PA, J Cyst Fibros, 1/1/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • "The Airway Microbiome: Lessons from Cystic Fibrosis Studies" 
    Carmel, CA - 1/1/2016
  • "Clinical Implications of the CF Airway Metagenome" 
    Basel, Swizterland - 1/1/2016
  • "Adult Cystic Fibrosis Clinical Phenotyping: The Application of the Statistical Learning Algorithm, Random Forest, to the Generation and Description of Adult Clinical ... 
    1/1/2015
  • Join now to see all

Other

  • Arachidonate 15-Lipoxygenase: Immunocytochemical Localization in Blood and Airway Cells. 
    Nadel JA, Ueki IF, Schuster A, Conrad DJ and E Sigal, 1990 Transactions of the Association of American Physicians
    1/1/1990

Grant Support

  • Molecular Mechanisms Of 15-Lipoxygenase ExpressionNational Heart, Lung, And Blood Institute1996–1998
  • Molecular Mechanisms Of 15-Lipoxygenase ExpressionNational Heart, Lung, And Blood Institute1994–1996

Hospital Affiliations